Tixagevimab plus cilgavimab - Covid-19
You are here : Home > Formulary Search > Tixagevimab plus cilgavimab - Covid-19
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Intramuscular injection (IM)
Formulary Status :
Restrictions / Comments :
Important
Not recommended under NICE TA971
Documents :
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Tixagevimab plus cilgavimab
Indication :
Covid-19
Group Name :
Keywords :
CMDu, covid medicines delivery unit, Covid antivirals, antivirals for Covid, NICE
Brand Names Include :
Evusheld
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Other Indications
Below are listed other indications that Tixagevimab plus cilgavimab is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Covid-19.
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committed agreed a NON-FORMULARY traffic light status for Tixagevimab plus cilgavimab in line with NICE971 & NICE TA900